← FDA DRUG APPROVALS

FDA ANDA · ANDA207368

METHADONE HYDROCHLORIDE

Sponsor: SPECGX LLC

APPLICATION
ANDA207368
TYPE
ANDA
ORIGINAL APPROVAL
2019-08-22
LATEST ACTION
2021-02-18
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Prescription

Products

METHADONE HYDROCHLORIDEPrescription
METHADONE HYDROCHLORIDE 10MG/ML · CONCENTRATE · ORAL

Approval history

2021-02-18Labeling · Supplement 2 · standardAP
2019-08-22UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →